Liver Support with Fractionated Plasma Separation and Adsorption and Prometheus®

  • K. Rifai
  • C. Tetta
  • C. Ronco
Conference paper


The liver performs multiple metabolic functions ranging from protein synthesis to gluconeogenesis, metabolism of amino acids, lipids and urea, and the detoxification of drugs and by-products of intermediate metabolism. The liver also acts in the regulation of the immune system and the metabolism of many hormones. As a consequence, liver insufficiency is catastrophic both at the metabolic and the clinical level, giving rise to a multiple organ failure (MOF) syndrome characterized by encephalopathy, jaundice, coagulopathy, and an imbalance of the immune system. At the same time, a multiplicity of toxic substances, both lipophylic and hydrophylic, are released into the systemic circulation, thus altering many enzymatic cellular processes. The lipophylic substances interfere with structural cellular processes, such as the reconstruction of cellular membranes, while the hydrophilic ones alter and block functional processes both enzymatic and non-enzymatic in nature.


Liver Failure Hepatic Encephalopathy Acute Liver Failure Liver Support Chronic Liver Failure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Stadibauer V, Jalan R (2007) Acute liver failure: Liver support therapies. Curr Opin Crit Care 13:215–221CrossRefGoogle Scholar
  2. 2.
    Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M (1999) Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 31:1080–1085PubMedCrossRefGoogle Scholar
  3. 3.
    Stange J, Hassanein TI, Mehta R, Mitzner SR, Bartlett RH (2002) The molecular adsorbent recycling system (as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective randomized, controlled clinical trial, and clinical experience from 19 centres. Artif Organs 26:103–110PubMedCrossRefGoogle Scholar
  4. 4.
    Strobl W, Vogt G, Mitteregger R, Schönhofen M, Gerner FJ, Falkenhagen D (1998) [The fractionated plasma separation and adsorption system (PFSA), a new membrane adsorptionassisted adjunctive extracorporeal blood purification system for liver failure]. Biomed Tech (Berl) 43 Suppl:168–169CrossRefGoogle Scholar
  5. 5.
    Falkenhagen D, Strobl W, Vogt G, et al (1999) Fractionated plasma separation and adsorption system. A novel system for blood purification to remove albumin-bound substances. Artif Organs 23:81–89PubMedCrossRefGoogle Scholar
  6. 6.
    Rifai K, Ernst T, Kretschmer U, et al (2003) Prometheus — a new extracorporeal system for the treatment of liver failure. J Hepatol 39:984–990PubMedCrossRefGoogle Scholar
  7. 7.
    Krisper P, Haditsch B, Stauber R, et al (2005) In vivo quantification of liver dialysis: Comparison of albumin dialysis and fractionated plasma separation. J Hepatol 43:451–457PubMedCrossRefGoogle Scholar
  8. 8.
    Evenpoel P, Laleman W, Wilmer A, et al (2006) Prometheus versus Molecular Adsorbents Recirculating system: comparison of efficiency in two different liver detoxification devices. Artif Organs 30:276–284Google Scholar
  9. 9.
    Krisper P, Stauber RE (2007) Technology insight: artificial extracorporeal liver support: how does Prometheus compare with MARS? Nature Clin Practice Nephrology 3: 267–276CrossRefGoogle Scholar
  10. 10.
    Evenepoel P, laleman W, Wilmer A, et al (2005) Detoxifying capacity and kinetics of prometheus°a new extracorporeal system for the treatment of liver failure. Blood Purif 23: 349–358Google Scholar
  11. 11.
    Jalan R, Williams R (2002) Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 20: 252–261PubMedCrossRefGoogle Scholar
  12. 12.
    Kjaergard LL, Liu J, Als-Nielsen B, Gluud C (2003) Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 289:217–222PubMedCrossRefGoogle Scholar
  13. 13.
    Rifai K, Manns MP (2006) Review article: clinical experience with Prometheus. Ther Apher Dial 10:132–137PubMedCrossRefGoogle Scholar
  14. 14.
    Rifai K, Ernst T, Kretschmer U, et al (2005) The Prometheus® device for extracorporeal support of combined liver and renal failure. Blood Purif 23:298–302PubMedCrossRefGoogle Scholar
  15. 15.
    Kramer L, Bauer E, Schenk P, et al (2003) Successful treatment of refractory cerebral oedema in ecstasy/cocaine-induced fulminant hepatic failure using a new high-efficacy liver detoxification device (FPSA-Prometheus). Wien Klin Wochenschr 115:599–603PubMedGoogle Scholar
  16. 16.
    Skwarek A, Grodzicki M, Nyckowski P, et al (2006) The use Prometheus FPSA system in the treatment of acute liver failure: preliminary results. Transplant Proc 38:209–211PubMedCrossRefGoogle Scholar
  17. 17.
    Jung O, Asbe-Vollkopf A, Betz C, et al (2007) Long-term therapy of acute chronic liver failure to successful transplantation with an extracorporeal liver support system. Z Gastro 45:21–24CrossRefGoogle Scholar
  18. 18.
    Rifai K, Hafer C, Rosenau J, et al (2006) Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus®). Scand J Gastroenterol 41:1212–1217PubMedCrossRefGoogle Scholar
  19. 19.
    Laleman W, Wilmer A, Evenepoel P, et al (2006) Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic hemodynamics and vasoactive agents in patients with acut-on-chronic alcoholic liver failure. Crit Care 10:R108PubMedCrossRefGoogle Scholar
  20. 20.
    Stadibauer V, Krisper P, Aigner R, et al (2006) Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure. Crit Care 10:R169CrossRefGoogle Scholar
  21. 21.
    Rifai K, Ernst T, Kretschmer U, et al (2006) Removal selectivity of Prometheus — a new extracorporeal liver support device. World J Gastroenterol 12:940–944PubMedGoogle Scholar
  22. 22.
    Meijers BKI, Verhamme P, Nevens F, et al (2007) Major coagulation disturbances during fractionated plasma separation and adsorption. Am J Transpl 7:2195–2199CrossRefGoogle Scholar

Copyright information

© Springer Science + Business Media Inc. 2008

Authors and Affiliations

  • K. Rifai
    • 1
  • C. Tetta
    • 2
  • C. Ronco
    • 3
  1. 1.Department of Gastroenterology, Hepatology, and EndocrinologyMedical SchoolHannoverGermany
  2. 2.International Research and DevelopmentFresenius Medical Care Deutschland GmbHBad HomburgGermany
  3. 3.Department of Nephrology, Dialysis and Renal TransplantationSan Bortolo HospitalVicenzaItaly

Personalised recommendations